(S)-5-Amino-2-((S)-2-aminopropanamido)-5-oxopentanoic acid

Catalog No. :
ACFOMK730
CAS No. :
39537-23-0
Molecular Formula :
C8H15N3O4
Molecular Weight :
217.23

IUPAC Name:L-alanyl-L-glutamine

(S)-5-Amino-2-((S)-2-aminopropanamido)-5-oxopentanoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
500g97%$207.00Login to see priceIn stockInquiry
1000g97%$361.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-5-Amino-2-((S)-2-aminopropanamido)-5-oxopentanoic acid
IUPAC NameL-alanyl-L-glutamine
MDL No.MFCD00133046
Molecular FormulaC8H15N3O4
Molecular Weight217.23
SMILESO=C(N)CC[C@@H](C(O)=O)NC([C@H](C)N)=O
InChI KeyHJCMDXDYPOUFDY-WHFBIAKZSA-N
SynonymAla-Gln, BioReagent, suitable for cell culture, suitable for insect cell culture | AS-12601 | Dipeptamin | DTXSID20192658 | N(2)-L-Alanyl-L-glutamine | DB11876 | CHEBI:73788 | SCHEMBL133887 | L-Alanyl-L-glutamine, United States Pharmacopeia (USP) Referenc
CAS No.39537-23-0
PubChem CID123935

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACFOMK730 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDRZT485 route compound structure diagram
    ACDRZT4852491-20-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFOMK730 route product structure diagram
    ACFOMK73039537-23-0 In Stock
Inquiry

2. ACFOMK730 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACFOMK730 route product structure diagram
    ACFOMK73039537-23-0 In Stock
Inquiry

Comments (0)